{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T12:17:25Z","timestamp":1782562645245,"version":"3.54.5"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007232","name":"Radiumhemmets Forskningsfonder","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007232","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002794","name":"Cancerfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004047","name":"Karolinska Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The prognostic role of lymphadenectomy during esophagectomy for esophageal cancer in complete responders to neoadjuvant therapy is uncertain. This study aimed to help clarify this question.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients and Methods<\/jats:title>\n                    <jats:p>This was a bi-national population-based cohort study in Sweden (2006\u20132024) and Finland (2006\u20132019). The main cohort included 515 patients with esophageal cancer who underwent esophagectomy after complete or near-complete tumor response without lymph node metastasis following neoadjuvant therapy. A secondary cohort included 669 patients with similar tumor response, regardless of nodal status. Data came from medical records and national health data registers. Associations between lymphadenectomy (categorized in quartiles) and 5-year mortality were assessed using multivariable Cox regression, yielding hazard ratios (HR) with 95% confidence intervals (CI), adjusted for age, sex, country, comorbidity, type of neoadjuvant therapy, calendar year, tumor histology, hospital volume, tumor location, tumor response, and T stage.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In the main cohort, comparing the highest quartile of lymphadenectomy (\u2265 27 nodes) with the lowest (0\u201311 nodes) indicated decreased 5-year all-cause mortality (HR 0.54, 95% CI 0.34\u20130.88). Stratified analyses suggested no significant association for complete responders (HR 0.68, 95% CI 0.39\u20131.16), but for near-complete responders (HR 0.32, 95% CI 0.14\u20130.72). The associations disappeared when assessing stage purification bias in the secondary cohort (\n                      <jats:italic>n<\/jats:italic>\n                      = 669), with the corresponding HRs of 0.91 (95% CI 0.63\u20131.32) for all responders, 1.01 (95% CI 0.61\u20131.66) for complete responders, and 0.79 (95% CI 0.47\u20131.33) for near-complete responders. Results were similar for 5-year disease-specific mortality.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>After considering stage purification bias, more extensive lymphadenectomy did not improve the long-term survival among patients with complete or near-complete tumor response after neoadjuvant therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1245\/s10434-025-18599-6","type":"journal-article","created":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T16:52:00Z","timestamp":1762447920000},"page":"2065-2073","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The Prognostic Role of Lymphadenectomy during Esophagectomy for Esophageal Cancer with Complete or Near-Complete Tumor Response after Neoadjuvant Therapy"],"prefix":"10.1245","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1054-512X","authenticated-orcid":false,"given":"Wilhelm","family":"Leijonmarck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredrik","family":"Mattsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eivind","family":"Gottlieb-Vedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellinor","family":"Wistr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joonas H.","family":"Kauppila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"FINEGO group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olli","family":"Helminen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mika","family":"Helmio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heikki","family":"Huhta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Junttila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vesa","family":"Koivukangas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arto","family":"Kokkola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elina","family":"Lietzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Louhimo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanna","family":"Merilainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vesa-Matti","family":"Pohjanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuomo","family":"Rantanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ari","family":"Ristimaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jari V","family":"Rasanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eero","family":"Sihvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuula","family":"Tyrvainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antti","family":"Valtola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joonas H.","family":"Kauppila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesper","family":"Lagergren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,6]]},"reference":[{"issue":"3","key":"18599_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin."},{"issue":"22","key":"18599_CR2","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1056\/NEJMoa1112088","volume":"366","author":"P van Hagen","year":"2012","unstructured":"van Hagen P, Hulshof MC, van Lanschot JJ, Steyerberg EW, van Berge Henegouwen MI, Wijnhoven BP, et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med. 2012;366(22):2074\u201384.","journal-title":"N Engl J Med."},{"issue":"4","key":"18599_CR3","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1056\/NEJMoa2409408","volume":"392","author":"J Hoeppner","year":"2025","unstructured":"Hoeppner J, Brunner T, Schmoor C, Bronsert P, Kulemann B, Claus R, et al. Perioperative chemotherapy or preoperative chemoradiotherapy in esophageal cancer. N Engl J Med. 2025;392(4):323\u201335.","journal-title":"N Engl J Med."},{"issue":"5","key":"18599_CR4","doi-asserted-by":"publisher","first-page":"3167","DOI":"10.1245\/s10434-025-17007-3","volume":"32","author":"E Lundberg","year":"2025","unstructured":"Lundberg E, Mattsson F, Gottlieb-Vedi E, Lagergren J. Time trends in survival after surgery for esophageal cancer in a national population-based study in Sweden. Ann Surg Oncol. 2025;32(5):3167\u201374.","journal-title":"Ann Surg Oncol."},{"issue":"4","key":"18599_CR5","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/jso.21209","volume":"99","author":"G Darling","year":"2009","unstructured":"Darling G. The role of lymphadenectomy in esophageal cancer. J Surg Oncol. 2009;99(4):189\u201393.","journal-title":"J Surg Oncol."},{"issue":"10","key":"18599_CR6","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.annonc.2022.07.003","volume":"33","author":"R Obermannov\u00e1","year":"2022","unstructured":"Obermannov\u00e1 R, Alsina M, Cervantes A, Leong T, Lordick F, Nilsson M, et al. Oesophageal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up\u2606. Ann Oncol. 2022;33(10):992\u20131004.","journal-title":"Ann Oncol."},{"issue":"1","key":"18599_CR7","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1097\/SLA.0b013e3181b2f6ee","volume":"251","author":"NP Rizk","year":"2010","unstructured":"Rizk NP, Ishwaran H, Rice TW, Chen LQ, Schipper PH, Kesler KA, et al. Optimum lymphadenectomy for esophageal cancer. Ann Surg. 2010;251(1):46\u201350.","journal-title":"Ann Surg."},{"issue":"2","key":"18599_CR8","doi-asserted-by":"publisher","first-page":"119","DOI":"10.21037\/acs.2017.03.14","volume":"6","author":"TW Rice","year":"2017","unstructured":"Rice TW, Patil DT, Blackstone EH. 8th edition AJCC\/UICC staging of cancers of the esophagus and esophagogastric junction: application to clinical practice. Ann Cardiothorac Surg. 2017;6(2):119\u201330.","journal-title":"Ann Cardiothorac Surg."},{"issue":"1","key":"18599_CR9","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa055531","volume":"355","author":"D Cunningham","year":"2006","unstructured":"Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJ, Nicolson M, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 2006;355(1):11\u201320.","journal-title":"N Engl J Med."},{"issue":"2","key":"18599_CR10","doi-asserted-by":"publisher","first-page":"034","DOI":"10.1093\/bjs\/znae034","volume":"111","author":"SPG Henckens","year":"2024","unstructured":"Henckens SPG, Liu D, Gisbertz SS, Kalff MC, Anderegg MCJ, Crull D, et al. Prognostic value of Mandard score and nodal status for recurrence patterns and survival after multimodal treatment of oesophageal adenocarcinoma. Br J Surg. 2024;111(2):034.","journal-title":"Br J Surg."},{"issue":"13","key":"18599_CR11","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1200\/JCO.2015.65.2875","volume":"34","author":"SR Markar","year":"2016","unstructured":"Markar SR, Mackenzie H, Lagergren P, Hanna GB, Lagergren J. Surgical proficiency gain and survival after esophagectomy for cancer. J Clin Oncol Off J Am Soc Clin Oncol. 2016;34(13):1528\u201336.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol."},{"issue":"10","key":"18599_CR12","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-039574","volume":"10","author":"JH Kauppila","year":"2020","unstructured":"Kauppila JH, Ohtonen P, Rantanen T, Tyrv\u00e4inen T, Toikkanen V, P\u00e4\u00e4aho M, et al. Cohort profile: gastric cancer in the population-based, Finnish National Esophago-Gastric Cancer Cohort (FINEGO) Study. BMJ Open. 2020;10(10):e039574.","journal-title":"BMJ Open."},{"issue":"4","key":"18599_CR13","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1097\/01.sla.0000205825.34452.43","volume":"243","author":"M Lindblad","year":"2006","unstructured":"Lindblad M, Ye W, Lindgren A, Lagergren J. Disparities in the classification of esophageal and cardia adenocarcinomas and their influence on reported incidence rates. Ann Surg. 2006;243(4):479\u201385.","journal-title":"Ann Surg."},{"issue":"11","key":"18599_CR14","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1080\/0284186X.2020.1792547","volume":"59","author":"JH Kauppila","year":"2020","unstructured":"Kauppila JH. Completeness of esophageal cancer diagnosis in the Finnish Cancer Registry and hospital discharge registry, a nationwide study in Finland. Acta Oncol. 2020;59(11):1329\u201332.","journal-title":"Acta Oncol."},{"key":"18599_CR15","unstructured":"Nationellt v\u00e5rdprogram f\u00f6r matstrups- och mags\u00e4ckscancer. [Available from: https:\/\/kunskapsbanken.cancercentrum.se\/diagnoser\/matstrups-och-magsackscancer\/vardprogram\/."},{"key":"18599_CR16","unstructured":"National Board of Health and Welfare. Dodsorsaksregistrets framstallning och kvalitet [Available from: https:\/\/www.socialstyrelsen.se\/statistik-och-data\/register\/dodsorsaksregistret\/framstallning-och-kvalitet\/."},{"key":"18599_CR17","unstructured":"Statistics Finland. Causes of death: documentation of statistics [Available from: https:\/\/stat.fi\/en\/statistics\/documentation\/ksyyt\/2025-02-10."},{"issue":"5","key":"18599_CR18","doi-asserted-by":"publisher","first-page":"401","DOI":"10.3414\/ME17-01-0051","volume":"56","author":"N Brusselaers","year":"2017","unstructured":"Brusselaers N, Lagergren J. The Charlson Comorbidity Index in Registry-based Research. Methods Inf Med. 2017;56(5):401\u20136.","journal-title":"Methods Inf Med."},{"issue":"3","key":"18599_CR19","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1245\/s10434-022-12826-0","volume":"30","author":"M Uimonen","year":"2023","unstructured":"Uimonen M, Helminen O, B\u00f6hm J, Mrena J, Sihvo E. Standard lymphadenectomy for esophageal and lung cancer: variability in the number of examined lymph nodes among pathologists and its survival implication. Ann Surg Oncol. 2023;30(3):1587\u201395.","journal-title":"Ann Surg Oncol."},{"issue":"4","key":"18599_CR20","doi-asserted-by":"publisher","first-page":"065","DOI":"10.1093\/dote\/doad065","volume":"37","author":"N Schuring","year":"2024","unstructured":"Schuring N, van Berge Henegouwen MI, Gisbertz SS. History and evidence for state of the art of lymphadenectomy in esophageal cancer surgery. Dis Esophagus. 2024;37(4):065.","journal-title":"Dis Esophagus."},{"issue":"3","key":"18599_CR21","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1097\/SLA.0000000000005028","volume":"277","author":"E Gottlieb-Vedi","year":"2023","unstructured":"Gottlieb-Vedi E, Kauppila JH, Mattsson F, Hedberg J, Johansson J, Edholm D, et al. Extent of lymphadenectomy and long-term survival in esophageal cancer. Ann Surg. 2023;277(3):429\u201336.","journal-title":"Ann Surg."},{"issue":"1","key":"18599_CR22","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1001\/jamasurg.2015.2611","volume":"151","author":"J Lagergren","year":"2016","unstructured":"Lagergren J, Mattsson F, Zylstra J, Chang F, Gossage J, Mason R, et al. Extent of lymphadenectomy and prognosis after esophageal cancer surgery. JAMA Surg. 2016;151(1):32\u20139.","journal-title":"JAMA Surg."},{"issue":"2","key":"18599_CR23","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1097\/SLA.0000000000002824","volume":"269","author":"E Visser","year":"2019","unstructured":"Visser E, Markar SR, Ruurda JP, Hanna GB, van Hillegersberg R. Prognostic value of lymph node yield on overall survival in esophageal cancer patients: a systematic review and meta-analysis. Ann Surg. 2019;269(2):261\u20138.","journal-title":"Ann Surg."},{"issue":"5","key":"18599_CR24","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1097\/SLA.0000000000000965","volume":"260","author":"AK Talsma","year":"2014","unstructured":"Talsma AK, Shapiro J, Looman CWN, van Hagen P, Steyerberg EW, van der Gaast A, et al. Lymph node retrieval during esophagectomy with and without neoadjuvant chemoradiotherapy: prognostic and therapeutic impact on survival. Ann Surg. 2014;260(5):786\u201393.","journal-title":"Ann Surg."},{"issue":"13","key":"18599_CR25","doi-asserted-by":"publisher","first-page":"3743","DOI":"10.1245\/s10434-011-1753-9","volume":"18","author":"C Castoro","year":"2011","unstructured":"Castoro C, Scarpa M, Cagol M, Ruol A, Cavallin F, Alfieri R, et al. Nodal metastasis from locally advanced esophageal cancer: how neoadjuvant therapy modifies their frequency and distribution. Ann Surg Oncol. 2011;18(13):3743\u201354.","journal-title":"Ann Surg Oncol."},{"issue":"2","key":"18599_CR26","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1097\/SLA.0000000000004479","volume":"276","author":"S Sihag","year":"2022","unstructured":"Sihag S, Nobel T, Hsu M, Tan KS, Carr R, Janjigian YY, et al. A more extensive lymphadenectomy enhances survival after neoadjuvant chemoradiotherapy in locally advanced esophageal adenocarcinoma. Ann Surg. 2022;276(2):312\u20137.","journal-title":"Ann Surg."},{"issue":"5","key":"18599_CR27","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1097\/SLA.0000000000002389","volume":"266","author":"E Visser","year":"2017","unstructured":"Visser E, van Rossum PSN, Ruurda JP, van Hillegersberg R. Impact of lymph node yield on overall survival in patients treated with neoadjuvant chemoradiotherapy followed by esophagectomy for cancer: a population-based cohort study in the Netherlands. Ann Surg. 2017;266(5):863\u20139.","journal-title":"Ann Surg."},{"issue":"4","key":"18599_CR28","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1002\/jso.25846","volume":"121","author":"W Lutfi","year":"2020","unstructured":"Lutfi W, Martinez-Meehan D, Dhupar R, Christie N, Sarkaria I, Ekeke C, et al. Higher lymph node harvest in patients with a pathologic complete response after neoadjuvant therapy for esophageal cancer is associated with improved survival. J Surg Oncol. 2020;121(4):654\u201361.","journal-title":"J Surg Oncol."},{"issue":"3","key":"18599_CR29","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1053\/j.gastro.2019.10.039","volume":"158","author":"TD Azad","year":"2020","unstructured":"Azad TD, Chaudhuri AA, Fang P, Qiao Y, Esfahani MS, Chabon JJ, et al. Circulating tumor DNA analysis for detection of minimal residual disease after chemoradiotherapy for localized esophageal cancer. Gastroenterology. 2020;158(3):494-505.e6.","journal-title":"Gastroenterology."},{"issue":"5","key":"18599_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2025.109625","volume":"51","author":"R Kobayashi","year":"2025","unstructured":"Kobayashi R, Matsuda S, Nakamura K, Kawakubo H, Ho K, Morimoto Y, et al. Clinical value of preoperative circulating tumor DNA before surgery in patients with esophageal squamous cell carcinoma. Eur J Surg Oncol. 2025;51(5):109625.","journal-title":"Eur J Surg Oncol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-18599-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-025-18599-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-18599-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T12:39:48Z","timestamp":1770899988000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-025-18599-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,6]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["18599"],"URL":"https:\/\/doi.org\/10.1245\/s10434-025-18599-6","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,6]]},"assertion":[{"value":"6 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This work was supported by the Swedish Cancer Society and the Cancer Research Funds of Radiumhemmet. Eivind Gottlieb-Vedi reports consultancies for Sanofi, unrelated to the current study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}